Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
J Ovarian Res 17:9 Helvaci N, Okan YB (2025) Polycystic ovary syndrome as a metabolic disease
People with active or suspected cancer: Despite GHK-Cus anti-cancer potential, it theoretically could promote the formation of new blood vessels, which can feed tumors.3 9 14 People with anxiety or mood disorders: Similarly, although GHK-Cu has demonstrated an anxiolytic and anti-aggression effect in rats, the present research is too meager to support it as a viable treatment for anxiety or mood disorders
During GLP-1RA therapy, sustained hypophagia may further reduce effective micronutrient intake without immediately producing overt deficiency
Post-translational processing of proglucagon mRNA with PCs
